Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and Management of Type 2 Diabetic Kidney Disease
Simit Doshi, Allon N. Friedman
Clinical Journal of the American Society of Nephrology (2017) Vol. 12, Iss. 8, pp. 1366-1373
Open Access | Times Cited: 303

Showing 26-50 of 303 citing articles:

Molecular insights of diabetic nephropathy and chemical constituents-based treatment approach
Muhammed Amanat, Kanhaiya Lal, Thakur Gurjeet Singh, et al.
Phytochemistry Reviews (2025)
Closed Access | Times Cited: 1
Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
Michael S. Kelly, Jelena Lewis, Ashley Huntsberry, et al.
Postgraduate Medicine (2018) Vol. 131, Iss. 1, pp. 31-42
Open Access | Times Cited: 80
<p>Curcumin Inhibited Podocyte Cell Apoptosis and Accelerated Cell Autophagy in Diabetic Nephropathy via Regulating Beclin1/UVRAG/Bcl2</p>
Ping Zhang, Jie Fang, Jianping Zhang, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 641-652
Open Access | Times Cited: 55
Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
X Liu, Minjie Duan, Hao Huang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
Inhibition of PFKP in renal tubular epithelial cell restrains TGF-β induced glycolysis and renal fibrosis
Shu Yang, Han Wu, Yan-Chun Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 18
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease
Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 17
The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case–control study
Amal Ahmed Mohamed, Mona Abd Elmotaleb Hussein, Ihab Nabil Hanna, et al.
Medicina Clínica (2024) Vol. 162, Iss. 9, pp. e33-e39
Open Access | Times Cited: 8
A graminan type fructan from Achyranthes bidentata prevents the kidney injury in diabetic mice by regulating gut microbiota
Huayang Si, Yimeng Chen, Dejun HU, et al.
Carbohydrate Polymers (2024) Vol. 339, pp. 122275-122275
Closed Access | Times Cited: 8
Molecular mechanism of renal lipid accumulation in diabetic kidney disease
Zhengying Fang, Ruijie Liu, Jingyuan Xie, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 8
Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes
Tong‐Tong Liu, Hailing Zhao, Ying Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients
Jianguang Hu, Xiaoshi Zhong, Jing Yan, et al.
BMC Nephrology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Progression of diabetic kidney disease in T2DN rats
Oleg Palygin, Denisha Spires, Vladislav Levchenko, et al.
AJP Renal Physiology (2019) Vol. 317, Iss. 6, pp. F1450-F1461
Open Access | Times Cited: 44
Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice
Wenting Liu, Xiaowen Chen, Yuxian Wang, et al.
Pharmacological Research (2019) Vol. 150, pp. 104506-104506
Closed Access | Times Cited: 44
Systemic Inflammation Precedes Microalbuminuria in Diabetes
Florian G. Scurt, Jan Menne, Sabine Brandt, et al.
Kidney International Reports (2019) Vol. 4, Iss. 10, pp. 1373-1386
Open Access | Times Cited: 43
miR‐218 regulates diabetic nephropathy via targeting IKK‐β and modulating NK‐κB‐mediated inflammation
Li Mo, Qiushi Guo, Cai H, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 4, pp. 3362-3371
Closed Access | Times Cited: 43
Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates
Kalie L. Tommerdahl, Allison Shapiro, Edward Nehus, et al.
Pediatric Nephrology (2021) Vol. 37, Iss. 1, pp. 79-93
Open Access | Times Cited: 37
NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
Liang‐Jun Yan
Biomolecules (2021) Vol. 11, Iss. 5, pp. 730-730
Open Access | Times Cited: 36
Monocyte chemoattractant protein‐1 predicts the development of diabetic nephropathy
Florian G. Scurt, Jan Menne, Sabine Brandt, et al.
Diabetes/Metabolism Research and Reviews (2021) Vol. 38, Iss. 2
Open Access | Times Cited: 33
Interaction between Plasma Metabolomics and Intestinal Microbiome in db/db Mouse, an Animal Model for Study of Type 2 Diabetes and Diabetic Kidney Disease
Chenhua Wu, Jingjing Fei, Qing Xu, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 775-775
Open Access | Times Cited: 28
Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome
Qing Hou, Shuyan Kan, Zhuang Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
(Pro)renin receptor mediates tubular epithelial cell pyroptosis in diabetic kidney disease via DPP4-JNK pathway
Shiying Xie, Shicong Song, Sirui Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy
Zhipeng Diao, Hongmei Yu, Yapeng Wu, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Advancements in Diabetic Kidney Disease Management: Integrating Innovative Therapies and Targeted Drug Development
Shaarav Ghose, Matthew Satariano, Saichidroopi Korada, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 6, pp. E791-E806
Closed Access | Times Cited: 6
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 6
Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4
Lu Zhang, Zhengying Fang, Qingqing Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 5

Scroll to top